Jakupec MA - Search Results

1

Platinum(IV)-Loaded Degraded Glycol Chitosan as Efficient Platinum(IV) Drug Delivery Platform.

Lerchbammer-Kreith Y, Sommerfeld NS, Cseh K, Weng-Jiang X, Odunze U, Schätzlein AG, Uchegbu IF, Galanski MS, Jakupec MA, Keppler BK. Lerchbammer-Kreith Y, et al. Among authors: jakupec ma. Pharmaceutics. 2023 Mar 24;15(4):1050. doi: 10.3390/pharmaceutics15041050. Pharmaceutics. 2023. PMID: 37111536 Free PMC article.

2

Synthesis, structure, spectroscopic and in vitro antitumour studies of a novel gallium(III) complex with 2-acetylpyridine (4)N-dimethylthiosemicarbazone.

Arion VB, Jakupec MA, Galanski MS, Unfried P, Keppler BK. Arion VB, et al. Among authors: jakupec ma. J Inorg Biochem. 2002 Jul 25;91(1):298-305. doi: 10.1016/s0162-0134(02)00419-1. J Inorg Biochem. 2002. PMID: 12121788

3

Tumour-inhibiting platinum complexes--state of the art and future perspectives.

Jakupec MA, Galanski MS, Keppler BK. Jakupec MA, et al. Rev Physiol Biochem Pharmacol. 2003;146:1-54. doi: 10.1007/s10254-002-0001-x. Epub 2003 Feb 4. Rev Physiol Biochem Pharmacol. 2003. PMID: 12605304 Review.

4

Synthesis, X-ray diffraction structures, spectroscopic properties, and in vitro antitumor activity of isomeric (1H-1,2,4-triazole)Ru(III) complexes.

Arion VB, Reisner E, Fremuth M, Jakupec MA, Keppler BK, Kukushkin VY, Pombeiro AJ. Arion VB, et al. Among authors: jakupec ma. Inorg Chem. 2003 Sep 22;42(19):6024-31. doi: 10.1021/ic034605i. Inorg Chem. 2003. PMID: 12971773

5

Recent Developments in the Field of Tumor-Inhibiting Metal Complexes.

Galanski MS, Arion VB, Jakupec MA, Keppler BK. Galanski MS, et al. Among authors: jakupec ma. Curr Pharm Des. 2003;9(25):2078-89. doi: 10.2174/1381612033454180. Curr Pharm Des. 2003. PMID: 14529417 Review.

6

Synthesis, characterization, and in vitro antitumor activity of osteotropic diam(m)ineplatinum(II) complexes bearing a N,N-bis(phosphonomethyl)glycine ligand.

Galanski MS, Slaby S, Jakupec MA, Keppler BK. Galanski MS, et al. Among authors: jakupec ma. J Med Chem. 2003 Nov 6;46(23):4946-51. doi: 10.1021/jm0308040. J Med Chem. 2003. PMID: 14584945

7

The effect of cytoprotective agents in platinum anticancer therapy.

Jakupec MA, Galanski M, Keppler BK. Jakupec MA, et al. Met Ions Biol Syst. 2004;42:179-208. Met Ions Biol Syst. 2004. PMID: 15206103 Review. No abstract available.

8

Gallium and other main group metal compounds as antitumor agents.

Jakupec MA, Keppler BK. Jakupec MA, et al. Met Ions Biol Syst. 2004;42:425-62. Met Ions Biol Syst. 2004. PMID: 15206110 Review.

9

Synthesis, crystal structure and cytotoxicity of new oxaliplatin analogues indicating that improvement of anticancer activity is still possible.

Galanski MS, Yasemi A, Slaby S, Jakupec MA, Arion VB, Rausch M, Nazarov AA, Keppler BK. Galanski MS, et al. Among authors: jakupec ma. Eur J Med Chem. 2004 Aug;39(8):707-14. doi: 10.1016/j.ejmech.2004.04.003. Eur J Med Chem. 2004. PMID: 15276304

10

Intrinsic and acquired forms of resistance against the anticancer ruthenium compound KP1019 [indazolium trans-[tetrachlorobis(1H-indazole)ruthenate (III)] (FFC14A).

Heffeter P, Pongratz M, Steiner E, Chiba P, Jakupec MA, Elbling L, Marian B, Körner W, Sevelda F, Micksche M, Keppler BK, Berger W. Heffeter P, et al. Among authors: jakupec ma. J Pharmacol Exp Ther. 2005 Jan;312(1):281-9. doi: 10.1124/jpet.104.073395. Epub 2004 Aug 26. J Pharmacol Exp Ther. 2005. PMID: 15331656

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

181 results

Search Page

Filters